toxicity

You have access
End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report
MINH DUNG NGUYEN, OLENA GOROBETS, YANNICK JOEL DJOUA, JOHAN ROSE-DITE-MODESTINE, VINCENT VINH-HUNG, CLAIRE VERSCHRAEGEN and NAM P. NGUYEN

Anticancer Research June 2025, 45 (6) 2535-2538; DOI: https://doi.org/10.21873/anticanres.17625
You have access
Anticancer Potential of Black Ginseng Extract in a Breast Cancer Cell Xenograft Mouse Model
HYE JIN PARK, HA RIN NAMKUNG, SU BIN JUNG, KWANG-TAE CHOI and SEUNG TAE LEE

Anticancer Research March 2025, 45 (3) 1047-1054; DOI: https://doi.org/10.21873/anticanres.17491
Open Access
Early Urinary Potassium Level Predicts High-dose Methotrexate Elimination Delay in Primary Central Nervous System Lymphoma
VINCENT HARLAY, ALEXANDRE BERTUCCI, CÉLINE BOUCARD, GREGORIO PETRIRENA, CHANTAL CAMPELLO, MARYLINE BARRIÉ, DIDIER AUTRAN, OLIVIER CHINOT and EMELINE TABOURET

Anticancer Research October 2024, 44 (10) 4427-4433; DOI: https://doi.org/10.21873/anticanres.17272
You have access
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma
SANG HOON SEO, JEONG IL YU, HEE CHUL PARK, GYU SANG YOO, MOON SEOK CHOI, HYUNCHUL RHIM, MIN WOO LEE, SEUNGCHUL HAN, BORAM PARK and JI SUN SHIM

Anticancer Research May 2024, 44 (5) 2219-2230; DOI: https://doi.org/10.21873/anticanres.17029
You have access
Manganese as a Possible Anticancer Enhancer in Docetaxel Treatment of Prostate Cancer Cells
INGVAR HOLM, BODIL HERNROTH, AMANDA ROSANDER and HELENA TASSIDIS

Anticancer Research March 2024, 44 (3) 953-962; DOI: https://doi.org/10.21873/anticanres.16890
Open Access
Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer
MOTOKAZU SATO, QINGHONG HAN, YUTARO KUBOTA, ANTON BARANOV, DANIEL ARDJMAND, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, MICHAEL BOUVET, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research January 2024, 44 (1) 31-35; DOI: https://doi.org/10.21873/anticanres.16785
Open Access
Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery
YOSUKE TAKAKUSAGI, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, TADASHI KAMADA and HIROYUKI KATOH

Anticancer Research June 2023, 43 (6) 2691-2695; DOI: https://doi.org/10.21873/anticanres.16435
You have access
Comparison of Two Cisplatin Regimens for Chemoradiation in Patients With Squamous-cell Carcinoma of the Head and Neck
INGA ZWAAN, TAMER SOROR, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and DIRK RADES

Anticancer Research February 2023, 43 (2) 795-800; DOI: https://doi.org/10.21873/anticanres.16220
You have access
Differences in Toxicity Between Ashkenazi and Sephardic Jews With Colon Cancer Treated With Adjuvant Chemotherapy: A Prospective Study
BARUCH BRENNER, YAEL STERN, NOA GORDON, TZIPORA FUKS, TAL GRANOT, JULIET DREYER and AARON SULKES

Anticancer Research January 2023, 43 (1) 239-245; DOI: https://doi.org/10.21873/anticanres.16155
You have access
Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma
FRANCESCA DE FELICE, DANIELA MUSIO, MARIA SERPONE, GIANMARCO VAVALLE, CLAUDIA MARCHETTI and VINCENZO TOMBOLINI

Anticancer Research December 2022, 42 (12) 5909-5915; DOI: https://doi.org/10.21873/anticanres.16100

Main menu

User menu

Search

toxicity

Pages